-
AboutShanxi Nuocheng Pharmaceutical Co., Ltd. was established in August 2008. It is located in Huairen High-tech Industrial Park, Shuozhou City, Shanxi Province. It is a national "high-tech enterprise" and the company covers an area of 330 acres.
-
ProductsOur company can produce anti-tumor, anti-fungal, antibiotics, nutrition, anesthesia, cardiovascular and cerebrovascular products such as 6 categories of series of products, the company's existing domestic products 73 product specifications and foreign products 22 product specifications.
-
NewsFrom 2019 to now, the company has attracted 38 kinds of generic drugs developed by 12 scientific research institutes such as Beijing Tongrentang Pharmaceutical Technology Development Co., Ltd. and Shanghai Rongdi Biotechnology Co., Ltd. to land in our company. After all of them are put into production, the annual output value can be increased by 1 billion and the profit can be about 0.2 billion.
-
ProductionThe API synthesis workshop includes 2 API production lines, 4 supporting warehouses and a 800 ㎡ sewage treatment station. The workshop has complete functions and can realize multi-product sharing. The existing API varieties are fluorenylmethoxycarbonyl-N-hydroxysuccinic acid imide ester (Fmoc-OSu), cinepazide maleate, fasudil, cimetidine, dimidamol, glycyrrhizic acid monopotassium salt and other 8 API varieties.
-
QualityAs a key construction project in Shanxi Province, we have been affirmed, cared and cared for by leaders at all levels. Leaders at all levels of the province, city and county have visited our company many times to guide the research work.
Our company obtained "medical device registration certificate"
Date:
2012-03-23
On May 22, 2010, the general office of the Ministry of health of the people's Republic of China issued the notice on strengthening the prevention and control of nosocomial infection of non tuberculous mycobacteria (Wei Ban Yi Zheng Fa [2010] No. 88), which pointed out that non tuberculous mycobacteria are a kind of conditional pathogenic bacteria widely existing in nature, which exist in water, soil and aerosol, and can lead to infection of patients with low immunity. In recent years, some primary medical institutions have experienced outbreaks of non-tuberculous mycobacterial infections in patients' surgical incisions and injection sites due to unqualified sterilization and irregular use of surgical instruments, injection equipment and medical water, causing harm to patients' health,
Key words:
Biopharmaceuticals
2023-07-02
Norcheng Pharmaceuticals
Copyright©2023 Shanxi Nuocheng Pharmaceutical Co., Ltd.